JESSICA CHEPA: Open Payments
NPI 1629327713 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 18 payments from 9 companies in 2025. Trend: 2023 $19 · 2024 $637 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 7 | $290 |
| Ferring Pharmaceuticals Inc. | 2 | $233 |
| Janssen Biotech, Inc. | 2 | $109 |
| COLOPLAST CORP | 2 | $35 |
| ABBVIE INC. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $19 |
| SOBI, INC | 1 | $17 |
| Endo USA, Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: AMS 700, ADSTILADRIN, RYBREVANT, ERLEADA, Luja Coude, UBRELVY, Xtandi, Vonjo.
Industry payments across SC — which companies pay providers there.
